Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1979 Jun;36(3):442-8.

A longitudinal study of immunological parameters in multiple sclerosis: cell-mediated immunity and complement profiles

A longitudinal study of immunological parameters in multiple sclerosis: cell-mediated immunity and complement profiles

P Mar et al. Clin Exp Immunol. 1979 Jun.

Abstract

In a 1 year longitudinal study of twenty-two patients with multiple sclerosis (MS) and twenty-one normal control subjects, peripheral blood leucocytes were stimulated with lipoplysaccharide (LPS), a B cell mitogen, and phytohaemagglutinin (PHA) a T cell mitogen. EA- and EAC-rosette formation was also performed to assay null and B cells respectively, and the serum concentration of the C3 component of complement was determined. For ten multiple sclerosis (MS) patients with stationary phases of the disease, percentages of lymphocytes significantly lower than normal were found with normal leucocyte counts in the peripheral blood. Lymphocyte stimulation by PHA was significantly lower than normal in stable MS, while neither LPS stimulation nor EA- and EAC-rosette formation differed significantly from the controls. The C3 serum concentration was found to be significantly higher than normal. For nine out of twelve MS patients with a fluctuating clinical course, the C3 concentration was elevated during remission, but dropped to normal levels during relapse. None of the other parameters studied could be correlated with the clinical course.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ann N Y Acad Sci. 1965 Mar 31;122:429-38 - PubMed
    1. Lancet. 1976 Nov 6;2(7993):1023 - PubMed
    1. Dtsch Z Nervenheilkd. 1966 Mar 8;188(3):271-88 - PubMed
    1. Z Immunitatsforsch Allerg Klin Immunol. 1968 Jul;135(5):462-80 - PubMed
    1. Neurology. 1976 Jun;26(6 PT 2):47-8 - PubMed

LinkOut - more resources